New director shares vision for MSU’s Drug Discovery Program

(originally posted December 9, 2025 by the MSU COllege of Osteopathic Medicine): The Michigan State University Department of Pharmacology and Toxicology through the College of Osteopathic Medicine has named Andrea Joy Gonzales, Ph.D., as the new director of its Drug Discovery Program.

This position is supported through MSU’s Global Impact Initiative, designed to address global grand challenges and national priorities through the creation of more than 100 new faculty positions in some of the most promising – and critical – fields of research. Dr. Gonzales was preceeded by Dr. Richard Neubig, M.D. Ph.D., the founder and Director of the Drug Discovery Program since 2016. Dr. Gonzales emphasizes her immediate goals for Drug Discovery are to assess the program’s strengths and objectives, to continue to form partnerships with other MSU colleges and facilities and to put a bold vision in place that everyone can support.

The complete article welcoming Dr. Gonzales and outlining her bold vision for the future of MSU Drug Discovery can be found here.